Summary: Researchers report mice fed a high fat diet produce an enzyme called MMP-2, which results in leptin being blocked from binding to its receptors. This, they report, prevents neurons from signaling that the stomach is full. The study suggests blocking MMP-2 may help people with obesity to lose weight.
An international team of researchers has uncovered a destructive mechanism at the molecular level that causes a well-known phenomenon associated with obesity, called leptin resistance.
They found that mice fed a high-fat diet produce an enzyme named MMP-2 that clips receptors for the hormone leptin from the surface of neuronal cells in the hypothalamus. This blocks leptin from binding to its receptors. This in turn keeps the neurons from signaling that your stomach is full and you should stop eating.
This is the first time that a destructive molecular mechanism has been observed and described.
Scientists showed that when MMP-2 is blocked, leptin can still bind to the receptors and signal satiety. They hope that in the future, clinicians will be able to treat leptin resistance in humans by blocking MMP-2. They also have evidence that their findings have a broader scope.
“We opened a new field of study for metabolic disease,” said Rafi Mazor, a research scientist in the Department of Bioengineering at the University of California San Diego and the paper’s first author. “We need to ask what other pathways, in addition to leptin and its receptors, undergo a similar destructive process and what the consequences might be.”
Mazor is part of a team that includes researchers from the University of California San Diego, the Salk Institute for Biological Studies in La Jolla, Tel Aviv University in Israel and Monash University in Australia. The team presents their findings in the Aug. 22 issue of Science Translational Medicine.
While other research efforts have focused on studying pathways that block leptin from doing its job, Mazor and colleagues, under the lead of UC San Diego bioengineering professor Geert Schmid-Schonbein, decided to investigate the leptin receptor in the brain itself.
“Our hypothesis was that an enzyme breaking down proteins into amino acids and polypeptides can cleave membrane receptors and lead to dysfunctional activity,” Mazor said.
He and colleagues are calling for a large-scale clinical trial to investigate whether MMP-2 inhibitors might help people lose weight. Those in the early stages of being overweight might be clipping their leptin receptors, but their neural pathways are still intact, Schmid-Schonbein said. Receptors are able to regenerate but it’s unclear to what extent.
“When you block the protease that leads to the receptors not signaling, you can treat the issue,” said Schmid-Schonbein.
Leptin molecules are released from white fat tissue during a meal. They travel through the blood stream into the brain, specifically the hypothalamus, where they stimulate neural receptors to signal that the stomach is full. People who are obese often have plenty of leptin in their blood, but it fails to lead to signaling satiety.
Leptin resistance is a known process associated with obesity, but the molecular mechanisms by which it occurs were not understood.
Researchers first tested brain tissue from obese mice for protease activity. This is how they found MMP-2, the enzyme that they suspected was damaging leptin receptors. Mazor and colleagues then developed a method to tag leptin receptors to see what was happening to them. They observed that MMP-2 was damaging the receptors, which lost their ability to signal. Researchers then used a recombinant protein to verify that the MMP-2 enzyme was indeed cleaving leptin receptors. They also cultured brain cells from mice and found clipped receptors when MMP-2 was present.
Researchers genetically altered a group of mice to not produce MMP-2. In spite of being fed a high-fat diet, these mice gained less weight and their leptin receptors remained intact. Meanwhile, mice that were fed the same diet but were not genetically altered became obese and their leptin receptors were cleaved.
In the long run, researchers aim to design an MMP-2 inhibitor or an inhibitor for the MMP-2 pathway of activation. Next steps also include confirming that the same mechanism occurs in human brain cells. “In the future, we will try to find out why proteases are activated, what is activating them and how to stop it,” Mazor added. He and the team think that other membrane receptors may also be destroyed in the same way. “There is still a lot of work to do to better understand receptor cleaving and the loss of cell function while on a high-fat diet.”
About this neuroscience research article
Funding: The work was supported by grants from the National Institute of Health, the American Heart Association, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and the Foundation for Anesthesia Education & Research and the American Society of Critical Care Anesthesiologists.
Source: Ioana Patringenaru – UCSD Publisher: Organized by NeuroscienceNews.com. Image Source: NeuroscienceNews.com image is credited to Mazor et al. Original Research:Abstract for “Cleavage of the leptin receptor by matrix metalloproteinase–2 promotes leptin resistance and obesity in mice” by Rafi Mazor, Dinorah Friedmann-Morvinski, Tom Alsaigh, Oded Kleifeld, Erik B. Kistler, Liat Rousso-Noori, Cheng Huang, Joyce B. Li, Inder M. Verma and Geert W. Schmid-Schönbein in Science Translational Medicine. Published August 22 2018. doi:10.1126/scitranslmed.aah6324
Cite This NeuroscienceNews.com Article
[cbtabs][cbtab title=”MLA”]UCSD”Destructive Mechanism That Blocks the Brain from Knowing When to Stop Eating Identified.” NeuroscienceNews. NeuroscienceNews, 25 August 2018. <https://neurosciencenews.com/leptin-obesity-overeating-9739/>.[/cbtab][cbtab title=”APA”]UCSD(2018, August 25). Destructive Mechanism That Blocks the Brain from Knowing When to Stop Eating Identified. NeuroscienceNews. Retrieved August 25, 2018 from https://neurosciencenews.com/leptin-obesity-overeating-9739/[/cbtab][cbtab title=”Chicago”]UCSD”Destructive Mechanism That Blocks the Brain from Knowing When to Stop Eating Identified.” https://neurosciencenews.com/leptin-obesity-overeating-9739/ (accessed August 25, 2018).[/cbtab][/cbtabs]
Cleavage of the leptin receptor by matrix metalloproteinase–2 promotes leptin resistance and obesity in mice
Obesity and related morbidities pose a major health threat. Obesity is associated with increased blood concentrations of the anorexigenic hormone leptin; however, obese individuals are resistant to its anorexigenic effects. We examined the phenomenon of reduced leptin signaling in a high-fat diet–induced obesity model in mice. Obesity promoted matrix metalloproteinase–2 (Mmp-2) activation in the hypothalamus, which cleaved the leptin receptor’s extracellular domain and impaired leptin-mediated signaling. Deletion of Mmp-2 restored leptin receptor expression and reduced circulating leptin concentrations in obese mice. Lentiviral delivery of short hairpin RNA to silence Mmp-2 in the hypothalamus of wild-type mice prevented leptin receptor cleavage and reduced fat accumulation. In contrast, lentiviral delivery of Mmp-2 in the hypothalamus of Mmp-2−/− mice promoted leptin receptor cleavage and higher body weight. In a genetic mouse model of obesity, transduction of cleavage-resistant leptin receptor in the hypothalamus reduced the rate of weight gain compared to uninfected mice or mice infected with the wild-type receptor. Immunofluorescence analysis showed that astrocytes and agouti-related peptide neurons were responsible for Mmp-2 secretion in mice fed a high-fat diet. These results suggest a mechanism for leptin resistance through activation of Mmp-2 and subsequent cleavage of the extracellular domain of the leptin receptor.